4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Santhera Pharmaceuticals Holding AG (SANN) operates in the Biotechnology industry and is headquartered in Pratteln, Switzerland with about 93 employees. Its market capitalization is roughly CHF 242 million. In the fiscal year ended 2025-12-31, SANN reported CHF 77M in revenue and (CHF 49M) in net income.
Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | CHF 77M | CHF 39M | CHF 103M | CHF 8M | — |
| Gross Profit | CHF 15M | CHF 24M | CHF 100M | CHF 4M | — |
| Operating Income (EBIT) | (CHF 38M) | (CHF 33M) | CHF 51M | (CHF 52M) | — |
| Net Income | (CHF 49M) | (CHF 42M) | CHF 55M | (CHF 71M) | — |
CHF; CHFM / CHFB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | CHF 148M | CHF 152M | CHF 110M | CHF 64M | — |
| Total Liabilities | CHF 160M | CHF 125M | CHF 50M | CHF 107M | — |
CHF; CHFM / CHFB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive SANN viewer.
About TickerBase · Data methodology & sources · Privacy · Terms